Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07060495 · ClinicalTrials.gov registry record · Phase 3
RADA16 for Adult Tonsillectomy
A Phase 3 study of Postoperative Pain, sponsored by Rutgers, The State University of New Jersey.
- Recruiting
- Registry status
- Phase 3
- Development phase
- 134
- Enrollment target
- 2
- Study locations
NCT07060495 is a Phase 3 study of Postoperative Pain that is actively recruiting participants, run by Rutgers, The State University of New Jersey. The registered enrollment target is 134 participants, below the 229-participant average among 63 other Postoperative Pain trials with a reported enrollment target (41% lower). The trial reports 2 study locations across 1 state.
The verdict
NCT07060495, a Phase 3 study of Postoperative Pain, is actively recruiting participants, sponsored by Rutgers, The State University of New Jersey.
- RECRUITING
- Registry status
- Phase 3
- Development phase
- 134 participants
- Enrollment target
- 2
- Study locations
Study Summary
The purpose of the research is to determine if RADA16 (also known as PuraStat®, PuraGel®, or PuraSinus®) improves patient outcomes following tonsillectomy procedures. Researchers will compare application of device RADA16 to application of no device to see if RADA16 works to treat post tonsillectomy hemorrhage. Participants will: * Undergo tonsillectomy procedure. * Receive and fill out a survey sent via email every 2 days following their procedure for 15 days and track their symptoms.
Conditions Studied
Interventions
- DEVICE RADA16 hydrogel
Study Locations (2)
New Jersey
- Cooperman Barnabas Medical Center - Livingston
- University Hospital - Newark
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 134 participants |
| Start Date | 2025-09-12 |
| Est. Completion | 2026-09-01 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07060495
The ClinicalTrials.gov registry entry for NCT07060495 describes a study currently listed as recruiting, categorized as Phase 3. The registered enrollment target is 134 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 229-participant average among 63 other Postoperative Pain trials with a reported enrollment target (41% lower). The listed sponsor is Rutgers, The State University of New Jersey, which has 413 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Postoperative Pain appearing as the primary indexed condition, and to 1 intervention - of which RADA16 hydrogel is the first listed.
NCT07060495 reports 2 study locations spanning 1 distinct geographic area - top geographies include New Jersey.
Frequently Asked Questions
What is clinical trial NCT07060495 about?
NCT07060495 is a clinical study titled "RADA16 for Adult Tonsillectomy". The purpose of the research is to determine if RADA16 (also known as PuraStat®, PuraGel®, or PuraSinus®) improves patient outcomes following tonsillectomy procedures. Researchers will compare application of device RADA16 to application of no device to see if RADA16 works to treat post tonsillectomy...
What is the current status of trial NCT07060495?
This trial is currently recruiting. It is a Phase 3 study. The enrollment target is 134 participants. The study started on 2025-09-12. Estimated completion is 2026-09-01.
What conditions does trial NCT07060495 study?
This clinical trial studies the following conditions: Postoperative Pain.
What interventions are being tested in trial NCT07060495?
The interventions under investigation include: RADA16 hydrogel (DEVICE).
Who is sponsoring clinical trial NCT07060495?
This trial is sponsored by Rutgers, The State University of New Jersey, which has 413 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT07060495 being conducted?
This trial has 2 study locations across New Jersey. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Postoperative Pain
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of TLC590 for Postsurgical Pain Following Bunionectomy
RECRUITING · Phase 3
-
A Clinical Trial of Intravenous Lidocaine After Spinal Surgery to Prevent Delirium and Reduce Pain
RECRUITING · Phase 3
-
Perioperative Lidocaine and Ketamine in Abdominal Surgery
ACTIVE NOT RECRUITING · Phase 3
-
Comparison of the Safety of Q8003 Versus Morphine Equivalent Doses of Its Components (Oxycodone and Morphine) in Bunionectomy Patients
COMPLETED · Phase 3
-
Safety and Efficacy of Multiple Doses of Intranasal Ketorolac in Postoperative Pain Following Major Abdominal Surgery
COMPLETED · Phase 3
-
Efficacy and Safety of Intravenous Acetaminophen Over 48 Hrs for the Treatment of Post-op Pain After Gynecologic Surgery
COMPLETED · Phase 3
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.